Royce & Associates LP: Recent Portfolio Activity Analysis

For the quarter ending on June 30, 2026, Royce & Associates LP showed significant activity in its portfolio. The firm engaged in buying shares of several companies and exiting positions, reflecting strategic adjustments.

Among the notable additions this quarter are PETCO Health & Wellness Co I (WOOF), a Consumer Cyclical company. Royce also initiated positions in Avantor Inc (AVTR) (Healthcare) and Alight Inc (ALIT) (Technology). Furthermore, the firm took a stake in SOPHIA GENETICS SA (H82027105), which falls under the Healthcare sector despite its ticker not conforming to standard naming conventions.

Royce & Associates also demonstrated strong buying momentum in other areas. The firm increased its holdings significantly of Certara Inc (CERT) and Standard Biotools Inc (LAB), both within the Healthcare sector. Additionally, there was a substantial purchase of shares in Acv Auctions Inc (ACVA) under Consumer Cyclical and Kopin Corp (KOPN) in the Technology sector.

In contrast, Royce & Associates indicated exits or reductions for several holdings. The firm completely exited its position in Kopin Corp (KOPN) as the portfolio percentage allocation dropped to 0.0%. Similarly, it sold all shares of Comtech Telecommunications Corp (CMTL), which is also a Technology holding now showing zero allocation. The investor significantly reduced its stake in Mks Inc. (MKSI) and other Technology companies like Onto Innovation Inc (ONTO), though the latter saw a smaller reduction.

Furthermore, Royce & Associates sold shares of several stocks this quarter. Notably, it disposed of Catalyst Pharmaceuticals Inc (CPRX), reducing its allocation from 0.29% to 0.09%. The firm also exited positions in other Healthcare companies such as Standard Biotools Inc (LAB) and Certara Inc (CERT), although the data shows these were actually increases, indicating a potential error or different interpretation in the provided categories. Additionally, Royce sold its entire stake in SOPHIA GENETICS SA (H82027105) as the allocation dropped to 0.0%.

The overall portfolio structure remains dominated by Technology and Healthcare sectors, but this quarter's data shows active turnover across multiple industries including Consumer Cyclical, Basic Materials, Industrials, and Financial Services.